Skip to main content

Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis

Abstract

Nitric oxide (NO) is known to be critically involved in breast carcinogenesis. Genetic polymorphisms of the gene encoding for endothelial nitric oxide synthase (eNOS), the enzyme catalyzing the production of the NO, are known to predispose to malignant disease. Increasing evidences showed that eNOS plays a significant role in the development of breast cancer. However, published data on the association between eNOS 894 G>T polymorphism and breast cancer risk are inconclusive. In order to derive a more precise estimation of this relationship, a meta-analysis including 11 studies was performed. Crude odds ratios (ORs) with 95% confidence interval (CIs) were used to estimate the strength of the association. The results showed that there was a significant association with breast cancer risk in TT versus GG (OR = 1.22, 95% CI = 1.02–1.44, P = 0.272) and recessive model TT versus GG/GT (OR = 1.21, 95% CI = 1.02–1.42, P = 0.223). In summary, this meta-analysis primarily suggests that eNOS 894G>T polymorphism is associated with breast cancer.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43(2):109–142

    CAS  PubMed  Google Scholar 

  2. Bredt DS (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31(6):577–596

    CAS  Article  PubMed  Google Scholar 

  3. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG (2002) The role of nitric oxide in cancer. Cell Res 12(5–6):311–320

    Article  PubMed  Google Scholar 

  4. Chien YH, Bau DT, Jan KY (2004) Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair. Free Radic Biol Med 36(8):1011–1017

    CAS  Article  PubMed  Google Scholar 

  5. Jadeski LC, Chakraborty C, Lala PK (2003) Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer 06(4):496–504

    Article  Google Scholar 

  6. Loibl S, von Minckwitz G, Weber S, Sinn HP, Schini-Kerth VB, Lobysheva I, Nepveu F, Wolf G, Strebhardt K, Kaufmann M (2002) Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy. Cancer 95(6):1191–1198

    CAS  Article  PubMed  Google Scholar 

  7. Martin JH, Begum S, Alalami O, Harrison A, Scott KW (2002) Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 21(2):90–97

    Article  Google Scholar 

  8. Vakkala M, Paakko P, Soini Y (2000) eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 17(4):667–671

    CAS  PubMed  Google Scholar 

  9. Martin JH, Alalami O, van den Berg HW (1999) Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett 144(1):65–74

    CAS  Article  PubMed  Google Scholar 

  10. Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB (2002) Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol 86(2):134–137

    CAS  Article  PubMed  Google Scholar 

  11. Ahsan A, Norboo T, Baig MA, Qadar Pasha MA (2005) Simultaneous selection of the wild-type genotypes of the G894T and 4B/4A polymorphisms of NOS3 associate with high-altitude adaptation. Ann Hum Genet 69(3):260–267

    CAS  Article  PubMed  Google Scholar 

  12. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)→Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276(28):26674–26679

    CAS  Article  PubMed  Google Scholar 

  13. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103(1):65–69

    CAS  Article  PubMed  Google Scholar 

  14. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci USA 97(6):2832–2835

    CAS  Article  PubMed  Google Scholar 

  15. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20(10):2023–2027

    CAS  Article  PubMed  Google Scholar 

  16. Pance A (2006) Nitric oxide and hormones in breast cancer: allies or enemies? Future Oncol 2(2):275–288

    CAS  Article  PubMed  Google Scholar 

  17. Gatti G, Simsek S, Zurrida S, Kurne A, Giannetti I, Demirer S, Smeets A, Caldarella P, Vento AR, Giraldo A (2004) Possible role of nitric oxide in the biology of breast carcinoma: review of the available literature. Breast 13(1):1–6

    CAS  Article  PubMed  Google Scholar 

  18. Ghilardi G, Biondi ML, Cecchini F, DeMonti M, Guagnellini E, Scorza R (2003) Vascular invasion in human breast cancer is correlated to T→786C polymorphism of NOS3 gene. Nitric Oxide 9(2):118–122

    CAS  Article  PubMed  Google Scholar 

  19. Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE (2006) Promoter polymorphism (–786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107(9):2245–2253

    CAS  Article  PubMed  Google Scholar 

  20. Marangoni K, Araujo TG, Neves AF, Goulart LR (2008) The –786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. BMC Cancer 8:273–288

    Article  PubMed  Google Scholar 

  21. Hefler LA, Grimm C, Lantzsch T, Lampe D, Koelbl H, Lebrecht A, Heinze G, Tempfer C, Reinthaller A, Zeillinger R (2006) Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 98(2):151–155

    CAS  Article  PubMed  Google Scholar 

  22. Lee KM, Choi JY, Lee JE, Noh DY, Ahn SH, Han W, Yoo KY, Hayes RB, Kang D (2007) Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res Treat 106(3):433–438

    CAS  Article  PubMed  Google Scholar 

  23. Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, Rodriguez C, Thun MJ, Calle EE (2007) Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 16(9):1784–1794

    CAS  Article  PubMed  Google Scholar 

  24. Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, Hong CC (2009) Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 30(5):777–784

    CAS  Article  PubMed  Google Scholar 

  25. Yang J, Ambrosone CB, Hong CC, Ahn J, Rodriguez C, Thun MJ, Calle EE (2007) Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 28(6):1247–1253

    CAS  Article  PubMed  Google Scholar 

  26. Royo JL, Moreno-Nogueira JA, Galan JJ, Gonzalez-Martin A, Ruiz A, Gonzalez-Mancha R, Real LM (2006) Lack of association between NOS3 Glu298Asp and breast cancer risk: a case–control study. Breast Cancer Res Treat 100(3):331–333

    Google Scholar 

  27. Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML (2006) Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 12(23):7063–7070

    CAS  Article  PubMed  Google Scholar 

  28. Choi JY, Lee KM, Noh DY, Ahn SH, Lee JE, Han W, Jang IJ, Shin SG, Yoo KY, Hayes RB (2006) Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat 100(2):213–218

    CAS  Article  PubMed  Google Scholar 

  29. Choi JY, Barlow WE, Albain KS, Hong CC, Blanco JG, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF (2009) Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a southwest oncology group clinical trial. Clin Cancer Res 15(16):5258–5266

    CAS  Article  PubMed  Google Scholar 

  30. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826

    CAS  PubMed  Google Scholar 

  31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    CAS  Article  PubMed  Google Scholar 

  32. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    CAS  PubMed  Google Scholar 

  33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    CAS  PubMed  Google Scholar 

  34. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW, Muendlein A (2004) Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 101(2):264–269

    CAS  Article  PubMed  Google Scholar 

  35. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59(19):4870–4875

    CAS  PubMed  Google Scholar 

  36. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF (1999) Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 79(10):1215–1225

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Dr. Nora Tramm at the University of Chicago for English improvement and comments on the manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yongsheng Huang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hao, Y., Montiel, R. & Huang, Y. Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124, 809–813 (2010). https://doi.org/10.1007/s10549-010-0833-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0833-z

Keywords

  • NOS3
  • Polymorphism
  • Breast cancer
  • Meta-analysis